West Pharmaceutical Services Inc (WST)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 593,400 | 585,900 | 661,800 | 346,200 | 241,700 |
| Revenue | US$ in thousands | 2,918,500 | 2,886,900 | 2,831,600 | 2,146,900 | 1,839,900 |
| Net profit margin | 20.33% | 20.30% | 23.37% | 16.13% | 13.14% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $593,400K ÷ $2,918,500K
= 20.33%
The net profit margin of West Pharmaceutical Services, Inc. has shown a generally positive trend over the past five years, with fluctuations observed year over year. The company's net profit margin has ranged from 13.14% in 2019 to 23.37% in 2021, indicating varying levels of profitability during this period. In 2023, the net profit margin stood at 20.12%, representing a slight decrease from the previous year but remaining relatively strong. This performance suggests that West Pharmaceutical Services, Inc. has been able to effectively manage its expenses and generate a significant portion of revenue as net income. A higher net profit margin indicates that the company is efficient in converting revenue into profit after accounting for all expenses, reflecting positively on its financial health and operational efficiency.
Peer comparison
Dec 31, 2023